Zydus Wellness Ltd

Zydus Wellness Ltd

₹ 593 -1.54%
17 Jul 10:42 a.m.
About

Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)

Key Points

Business Segments:[1]
Zydus Wellness operates primarily in the consumer wellness sector. Its key segments include:
a)Food & Nutrition: Notable brands and products such as Glucon-D, Complan, and Sugar-Free.
b) Personal Care: This segment covers products like Everyuth, Scrubs Peel-off masks, and Nycil Prickly Heat Powder.

  • Market Cap 18,864 Cr.
  • Current Price 593
  • High / Low 608 / 358
  • Stock P/E 411
  • Book Value 127
  • Dividend Yield 0.20 %
  • ROCE 1.69 %
  • ROE 1.14 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 108%

Cons

  • Stock is trading at 4.75 times its book value
  • Company has a low return on equity of 0.89% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
59 60 58 64 63 63 63 100 128 141 156 153 133
51 53 50 53 56 58 56 85 114 125 128 132 113
Operating Profit 8 7 8 11 8 5 8 15 14 16 28 21 20
OPM % 14% 12% 13% 17% 12% 8% 12% 15% 11% 11% 18% 14% 15%
4 4 5 5 5 5 4 3 0 1 -8 3 5
Interest 0 0 1 1 1 1 0 1 2 2 2 3 3
Depreciation 1 1 1 1 1 1 1 1 7 6 6 6 6
Profit before tax 10 10 10 14 10 8 10 16 5 8 12 14 15
Tax % -173% 21% 25% 24% 29% 26% 24% 25% 29% 42% 34% 15% 12%
29 8 8 10 7 6 8 12 4 5 8 12 13
EPS in Rs 0.90 0.26 0.25 0.32 0.23 0.19 0.25 0.37 0.12 0.14 0.24 0.38 0.42
Raw PDF
Upcoming result date: 4 August 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
219 200 225 264 255 153 114 216 251 245 354 582
126 122 137 152 182 174 164 222 213 212 312 498
Operating Profit 93 78 88 112 72 -21 -50 -5 38 33 42 84
OPM % 42% 39% 39% 42% 28% -14% -44% -2% 15% 13% 12% 14%
20 30 25 28 57 109 -60 15 13 18 12 1
Interest 0 0 0 2 30 140 75 2 1 3 4 11
Depreciation 5 4 4 4 3 3 3 3 4 4 10 25
Profit before tax 109 104 109 134 97 -55 -188 5 47 45 40 49
Tax % -0% 1% -1% 0% 1% -26% -3% -143% -41% 25% 25% 23%
109 103 109 134 96 -41 -182 13 66 34 30 38
EPS in Rs 5.58 5.28 5.60 6.85 3.34 -1.41 -5.72 0.40 2.09 1.06 0.93 1.18
Dividend Payout % 22% 25% 23% 23% 30% -71% -17% 251% 48% 94% 128% 101%
Compounded Sales Growth
10 Years: 11%
5 Years: 39%
3 Years: 32%
TTM: 64%
Compounded Profit Growth
10 Years: -8%
5 Years: 23%
3 Years: -11%
TTM: 63%
Stock Price CAGR
10 Years: 14%
5 Years: 6%
3 Years: 27%
1 Year: 43%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 39 39 39 39 58 58 64 64 64 64 64 64
Reserves 367 440 518 652 3,268 3,157 3,956 3,937 3,971 3,972 3,970 3,969
0 0 25 25 1,566 1,516 50 46 0 51 130 181
45 19 23 23 62 72 47 44 32 29 88 60
Total Liabilities 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,116 4,251 4,273
44 43 40 38 37 43 44 45 54 54 432 420
CWIP 0 0 0 0 1 1 1 2 0 4 8 5
Investments 100 209 254 294 3,690 3,528 3,671 3,683 3,698 3,676 3,678 3,671
306 245 310 407 1,226 1,231 400 360 314 382 133 178
Total Assets 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,116 4,251 4,273

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
89 79 88 113 86 -20 -52 -16 37 26 40 35
70 -19 -78 -109 -4,131 267 816 39 1 -47 -88 -32
-27 -58 -6 -2 4,049 -260 -710 -38 -79 15 43 -0
Net Cash Flow 131 1 4 2 4 -13 54 -15 -42 -6 -5 3
Free Cash Flow 93 77 87 111 82 -28 -55 -21 25 20 29 27
CFO/OP 98% 103% 100% 99% 123% 96% 109% 255% 96% 80% 90% 44%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 1 0 1 1 9 1 5 19 4 12 25 17
Inventory Days 25 23 38 32 24 57 67 22 20 23 43 28
Days Payable 58 71 93 84 106 151 158 75 44 45 54 43
Cash Conversion Cycle -32 -48 -55 -50 -73 -93 -85 -34 -20 -10 13 3
Working Capital Days -63 -23 -61 -50 -104 -65 -145 -59 144 63 -76 0
ROCE % 30% 23% 21% 21% 4% 2% 0% 0% 1% 1% 1% 2%

Insights

In beta
Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Sugar Free Market Share (Sugar substitute category)
%

Log in to view insights

Please log in to see hidden values.

Login
Complan Market Share (Nutrition drink / HFD category)
%
Everyuth Market Share (Facial cleansing overall category)
%
Glucon-D Market Share (Glucose powder category)
%
Nycil Market Share (Prickly heat powder category)
%
Organised Trade Saliency (% of domestic revenue)
%
Direct Distribution Reach (Company direct coverage in lakhs of outlets)
lakhs of outlets
Total Reach (Distribution - stores in millions, Nielsen reported)
million stores

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
68.54% 69.15% 69.62% 69.62% 69.62% 69.62% 69.64% 69.64% 69.64% 69.64% 69.64% 69.63%
3.42% 3.25% 3.26% 3.29% 3.36% 3.37% 3.29% 3.25% 3.43% 3.27% 3.17% 3.32%
20.22% 19.67% 19.41% 19.44% 20.37% 20.12% 19.76% 19.27% 18.76% 18.58% 18.87% 19.13%
7.81% 7.91% 7.71% 7.65% 6.67% 6.89% 7.30% 7.83% 8.18% 8.51% 8.32% 7.92%
No. of Shareholders 76,59075,36969,13863,97360,98164,03764,97966,51477,18880,10580,67186,866

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls